(Q36367505)

English

PRL secreting adenomas in male patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

Europe PubMed Central

PRL secreting adenomas in male patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Annamaria Colao

7

object named as

Annamaria Colao

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Gaetano Lombardi

6

object named as

Gaetano Lombardi

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

author name string

Antonio Ciccarelli

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Ermelinda Guerra

2

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Michele De Rosa

3

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Francesco Milone

4

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Stefano Zarrilli

5

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

39-42

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

https://scigraph.springernature.com/pub.10.1007/s11102-005-5084-3

0 references

Growth-hormone and prolactin excess.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin Receptor Expression in Rat Spermatogenic Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of prolactin on the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diurnal rhythm of testosterone and luteinizing hormone in hypogonadal men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of prolactin on the metabolism of androgens by the rat ventral prostate gland in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperprolactinemia and impotence: why, when and how to investigate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactinomas in male and female patients: a comparative clinicopathologic study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16411067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11102-005-5084-3

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36367505&oldid=1628141543"